Intuitive Surgical clears fresh analyst hurdle, shares track technical levels on NASDAQ

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 21:01.

Intuitive Surgical (US46120E6023) stands out on Thursday with a stable analyst picture and active trading on NASDAQ, as recent consensus data and technical indicators frame the discussion around the stock. The company remains a key constituent of the S&P 500, which helps anchor international investor attention.

Analysts stick to upbeat views

Analyst coverage of Intuitive Surgical, Inc. remains broad, with major houses including Goldman Sachs, Morgan Stanley and JPMorgan among those following the stock and publishing regular earnings and valuation updates. Recent consensus collated by platforms such as MarketScreener still points to a predominantly positive stance, with a majority of analysts rating the shares Buy or Overweight, underlining a supportive sentiment backdrop for the medical robotics specialist. MarketScreener consensus overview for Intuitive Surgical

The company last reported quarterly figures in mid-April 2026, when Intuitive Surgical disclosed continued growth in procedures and system placements, reinforcing its structural position in minimally invasive surgery. While the next earnings date is not yet officially fixed in the investor-relations calendar, sell-side models typically work with a late-July reporting window, mirroring the timing pattern of previous years and giving investors a rough time frame for the next update on operating momentum. Intuitive Surgical investor-relations news archive

Technical view after recent range trading

On the chart, Intuitive Surgical shares have recently traded in a relatively narrow range on NASDAQ, with technicians watching support and resistance levels around the recent 50-day and 200-day moving averages. Data from charting services such as TradingView and Barchart show the stock hovering modestly above its 200-day line, a configuration that many investors consider consistent with a longer-term uptrend while still leaving room for short-term swings. Barchart technical overview for ISRG

Volatility in Intuitive Surgical shares has eased somewhat compared with the more pronounced moves seen around its last earnings release, according to trading statistics published by NASDAQ and major data aggregators. Average daily volume nonetheless remains robust, reflecting the stock's role as a widely held name among healthcare and technology-themed funds, and ensuring that chart signals like breakouts above recent highs or dips below short-term support tend to be closely monitored.

How Intuitive Surgical makes its money

Intuitive Surgical primarily generates revenue through its da Vinci robotic-assisted surgery systems, the associated instruments and accessories, and service contracts. Hospitals invest in the capital equipment and then pay recurring fees for disposable instruments and maintenance, which creates a mix of upfront and ongoing income tied to procedure volumes.

Where the stock trades today

Intuitive Surgical shares trade on NASDAQ under the ticker ISRG; the latest verified price data point shows the stock changing hands at around 400 US dollars per share as of 2026-06-25, based on NASDAQ and major quote services.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.